Alector (ALEC) Change in Receivables (2018)

Alector (ALEC) posted quarterly Change in Receivables of -$169000.0 for Q2 2018, down 144.93% quarter-over-quarter from -$69000.0 in Q1 2018.

Alector (ALEC) Change in Receivables (2018) Analysis & Trends

Alector (ALEC) has reported Change in Receivables for 1 consecutive years, with -$169000.0 the latest figure, recorded in Q2 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Receivables (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	140.20 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	838.50 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	117.58 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-483,662.49
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	31.60 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	37.16 Mn
10	Alector	218.85 Mn	46.05 Mn	-	-

Download Data